Faslodex in McCune Albright Syndrome

Mise à jour : Il y a 4 ans
Référence : NCT00278915

Femme Homme

Extrait

The purpose of this study is to evaluate the safety, effectiveness and pharmacokinetics of a study drug called Faslodex (fulvestrant) in the treatment of progressive precocious puberty (early puberty) in girls with McCune-Albright syndrome (MAS).


Critère d'inclusion

  • Puberty, Precocious ,McCune-Albright Syndrome


Liens